Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE)

NCT07714213 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

138

Enrollment

OTHER

Sponsor class

Conditions

Post-acute Infectious Syndrome (PAIS)
Post-COVID-19 Condition (PCC or Long COVID)

Interventions

DRUG: Aripiprazole (low-dose, 1mg)
DRUG: Placebo

Sponsor

Christiana Franke